Advanced Pharmacotherapy in Critical Care Online-Dexmedetomidine as Standard of Care: Are You the one Using Dexmedetomidine as a First Line Sedative in the ICU? (Joanna Stollings, PharmD, FCCP, BCPS, BCCCP, FCCM)

Dexmedetomidine as Standard of Care: Are You the one Using Dexmedetomidine as a First Line Sedative in the ICU? (Joanna Stollings, PharmD, FCCP, BCPS, BCCCP, FCCM)

Back to course

Video Transcription

Video Summary

Joanna Stallings, the Medical ICU Clinical Pharmacy Specialist at Vanderbilt University Medical Center, discussed the use of dexamethasone as a first-line sedative in the ICU. She highlighted the importance of avoiding benzodiazepines and considering non-benzodiazepine strategies, such as propofol and dexamethasone. Studies have shown that these alternatives are more effective in reducing delirium, shortening ICU stays, and improving patient outcomes. Costs analysis also revealed that dexamethasone is cost-effective and safe to use in patients with cardiogenic shock. Strategies like the ABCDF bundle and daily spontaneous awakening trials are essential in reducing sedative use in the ICU. Overall, the evidence supports the use of dexamethasone or propofol as the preferred sedatives in the ICU to improve patient care and outcomes while minimizing costs.

Keywords

Joanna Stallings

Medical ICU

Clinical Pharmacy Specialist

dexamethasone

benzodiazepines

propofol

ABCDF bundle

sedative use

	Society of Critical Care Medicine 500 Midway Drive Mount Prospect, IL 60056 USA Phone: +1 847 827-6888 Fax: +1 847 439-7226 Email: support@sccm.org	Contact Us About SCCM Newsroom Advertising & Sponsorship DONATE	MySCCM LearnICU Patients & Families Surviving Sepsis Campaign Critical Care Societies Collaborative	GET OUR NEWSLETTER
© Society of Critical Care Medicine. All rights reserved. \| Privacy Statement \| Terms & Conditions The Society of Critical Care Medicine, SCCM, and Critical Care Congress are registered trademarks of the Society of Critical Care Medicine.